AccessMyLibrary provides FREE access to millions of articles from top publications available through your library.

Insulin raises colorectal cancer risk in diabetics.(Brief Article)

GP

| October 22, 2004 | COPYRIGHT 2003 Haymarket Business Publications Ltd. (Hide copyright information)Copyright

Long-term insulin treatment could treble the risk of colorectal cancer (CRC) in patients with type-2 diabetes, according to an analysis of UK data.

US researchers analysed data from the UK General Practice Research Database.

The study included 24,918 patients with type-2 diabetes. Of these, 3,160 had received at least one year of insulin therapy.

Using data covering a 12-year period, the researchers found that patients who had been taking insulin for over a year were more than twice as likely to develop CRC than other type-2 diabetes patients. Further analysis revealed that CRC risk was associated with the duration of insulin treatment.

Related articles from newspapers, magazines, journals, and more
Study: Statins for reducing cholesterol reduce colorectal cancer risk.
News wire article from: Asia Africa Intelligence Wire May 26, 2005 700+ words
Obesity and colorectal cancer risk in women. (Colorectal Cancer).(Statistical...
Magazine article from: Gut Terry, P.D. Miller, A.B. Rohan, T.E. August 1, 2002 700+ words
Adenoma prevalence and cancer risk in familial non-polyposis colorectal...
Magazine article from: Gut Lindgren, G. Liljegren, A. Jaramillo, E. Rubio, C. Lindblom, A. February 1, 2002 700+ words
Does patient knowledge affect the colorectal cancer risk in ulcerative...
Magazine article from: Postgraduate Medical Journal Eaden, J.A. Abrams, K. Mayberry, J.F. October 1, 2002 700+ words
Colorectal cancer risk cut by asprin.
Magazine article from: GP November 4, 2011 700+ words
©2013 Gale, a part of Cengage Learning. All rights reserved. Contact us | Privacy policy | Terms and conditions

The AccessMyLibrary advertising network includes: womensforum.com GlamFamily